May 4, 2009
Daiichi Sankyo has filed lawsuits against companies that have obtained approval for generics of its antibacterial agent Cravit (levofloxacin). However, the sued companies will apply for NHI price listing in May claiming that the patent on levofloxacin has expired. Daiichi...read more